Johnson & Johnson Q3 Preview: Decline in profit is in the cards
Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q3 earnings results on Tuesday, October 15th, before market open.
What Trends Will Drive Johnson & Johnson's Q3 Results?
We expect the company to post revenue of $22.2 billion and earnings of $2.20 per share, broadly aligning with the consensus ...
The Motley Fool1d
Johnson & Johnson Q3 EPS Dips on Charges
In Q3 2024, Johnson & Johnson's innovative medicine segment reported a 6.3% operational sales growth, with oncology and immunology products leading the way. Substantial demand for Darzalex and ...
Johnson & Johnson Q3: Strengthening Cardiovascular Device Portfolio
Johnson & Johnson's Q3 results exceeded expectations, with 26.5% year-over-year growth in the cardiovascular market and a 5.4 ...
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...